ZYXI - EXCLUSIVE: Medical Devices Firm Zynex Launches New $20M Share Repurchase Program | Benzinga
Zynex Inc's (NASDAQ: ZYXI) board of directors approved a program to repurchase up to $20.0 million.
The program will commence on November 1, 2023, and is scheduled to terminate earlier than November 1, 2024, or when the $20.0 million limit is reached.
Tuesday, Zynex initiated a process to evaluate potential strategic alternatives, confirming a Bloomberg report from Monday. It has retained Cantor Fitzgerald & Co. as its financial advisor.
"Zynex recently announced strong earnings," said Thomas Sandgaard, Founder and ...